Levonorgestrel IUD for Adolescent Solid-Organ Transplant Recipients

Females who undergo solid organ transplants are at risk for unplanned pregnancy.

Our researchers conducted a case series to study the safety and efficacy of the levonorgestrel 52-mg intrauterine system (IUS) in adolescent and young adult solid organ transplant recipients. The retrospective study reviewed six transplant recipients who received the levonorgestrel 52-mg reversible intrauterine device (IUD). The organs transplanted were: liver, small bowel, kidney (2) and heart (2). There were no unintended pregnancies among the patients studied and there were no cases of pelvic inflammatory disease. While there are limitations to the study, including case size, this is the largest case series published in the adolescent and young adult transplant population, demonstrating the safety of the LNG 52-mg IUS in six solid organ transplant recipients.

Researchers determined that healthcare providers should feel comfortable using IUDs in this population.